The paper's citation list
No. | The paper's citation list |
|---|
1 | Current Strategies and Future Directions in Multiple Myeloma: Disease Overview and Pathophysiology, Conventional Treatments and Emerging Therapies, Challenges and Innovations in Management. 2024;2:10 doi: 10.59324/ejmhr.2024.2(5).02 |
2 | A review of recent clinical trials to evaluate disease-modifying therapies in the treatment of cardiac amyloidosis. 2024;11: doi: 10.3389/fmed.2024.1477988 |
3 | A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma. 2023;15:4533 doi: 10.3390/cancers15184533 |
4 | Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma. 2023;13: doi: 10.3389/fonc.2023.1141851 |
5 | Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction. 2022;10: doi: 10.3389/fcell.2022.1059715 |
6 | Machine Learning Approach for Rapid, Accurate Point-of-Care Prediction of M-Spike Values in Multiple Myeloma. 2023; doi: 10.1200/CCI.23.00078 |
7 | Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. 2023;15:5632 doi: 10.3390/cancers15235632 |
8 | Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients. 2025;114:105 doi: 10.1111/ejh.14314 |
9 | Road testing new CAR design strategies in multiple myeloma. 2022;13: doi: 10.3389/fimmu.2022.957157 |
